Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Harmon.Health vs NuuVim

By GLP-1 ScorecardUpdated

Harmon.Health
Site position #72

Higher score

NuuVimFactor scores not reassessed.
Site position #113

Lower score

Score comparison

Harmon.Health has the higher recorded score — 74/100 to 70.6/100.

Harmon.Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Harmon.Health sells compounded semaglutide and tirzepatide at one price for every dose, plus dissolving tablets and the brand Wegovy pill, but its site links to no published terms.

Before you choose

Before comparing the headline prices, the Harmon.Health review and the NuuVim review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Harmon.Health vs PreventiveMD and No BS RX vs NuuVim compare each of them with another graded program, and the list of alternatives to Harmon.Health ranks the programs closest to Harmon.Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNuuVim +5
83
88
Dose & formulationEven
96
96
Clinical oversightHarmon.Health +14
68
54
Labs & monitoringHarmon.Health +1
51
50
FulfillmentHarmon.Health +9
70
61
Contract termsHarmon.Health +8
55
47
Harmon.Health · top barNuuVim · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricHarmon.HealthNuuVim
WeighScore74/10070.6/100
GradeCC
Site position#72#113
Semaglutide$149/mo (month-to-month; $389 billed quarterly or $1,249 yearly, same price at every dose, compounded)$79/mo (all doses, 3-mo plan, new patients only, compounded)
Tirzepatide$199/mo (month-to-month; $499 billed quarterly or $1,599 yearly, same price at every dose, compounded)$133/mo (all doses, 3-mo plan, new patients only, compounded)
CoverageAll states except MississippiCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
Harmon.Health

Site position #72 · C

Strengths

  • Same price at every dose, with quarterly and yearly plans
  • Offers injections, dissolving tablets and the brand Wegovy pill
  • Serves every state except Mississippi

What to consider

  • The Terms of Service, telehealth consent and privacy notice links in the footer lead nowhere
  • Neither the prescribing physicians nor the pharmacies are named
  • Introductory prices run until December 1, 2026, and some prices depend on a separate club membership
NuuVim

Site position #113 · C

Factor scores not reassessed.

Strengths

  • Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
  • Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
  • LegitScript Certified and HIPAA-compliant
  • Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
  • Operating legal entity disclosed: NuuVim LLC, Texas governing law

What to consider

  • There is no month-to-month plan: every rate is billed as one three-month payment
  • The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
  • The site's own llms.txt advertises pricing, FAQ and terms files that all 404
  • No state count is published

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard